Marshall Wace North America’s Axogen AXGN Stock Holding History

Marshall Wace North America’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,195	Closed	-$119K	–	1306
2020 Q3	$119K	Buy	+10,195	New	+$118K	﹤0.01%	1155
2019 Q4	–	Sell	-9,465	Closed	-$118K	–	1281
2019 Q3	$118K	Buy	+9,465	New	+$156K	﹤0.01%	1033
2019 Q2	–	Sell	-5,160	Closed	-$109K	–	1155
2019 Q1	$109K	Sell	5,160 -3,205	-38%	-$58.5K	﹤0.01%	1099
2018 Q4	$171K	Sell	8,365 -354,107	-98%	-$11.1M	﹤0.01%	982
2018 Q3	$13.4M	Sell	362,472 -13,070	-3%	-$571K	0.09%	181
2018 Q2	$18.9M	Buy	+375,542	New	+$16.5M	0.11%	218

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's AXGN Position: Q4 2020 in Review

Marshall Wace North America sold out of Axogen (AXGN) in Q4 2020, closing a stake of 10,195 shares — an estimated $119K sold.

Marshall Wace North America first reported a position in AXGN in Q2 2018 and held it in 6 quarters. The position peaked at $18.9M in Q2 2018. 121 funds tracked by Wall St. Rank hold AXGN as of Q4 2020.

Marshall Wace North America reported no remaining Axogen position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 10,195 Axogen shares in Q4 2020, an estimated $119K.
Marshall Wace North America first reported a position in Axogen in Q2 2018 and held it in 6 quarters.
Marshall Wace North America's Axogen position peaked at $18.9M in Q2 2018.
121 funds tracked by Wall St. Rank held Axogen as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.